Skip to content

Clinical Study of Silver Needle Thermal Conduction Therapy Combined with High Intensity Laser in the Treatment of Lumbar and Back Myofascitis

Clinical Study of Silver Needle Thermal Conduction Therapy Combined with High Intensity Laser in the Treatment of Lumbar and Back Myofascitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020080
Enrollment
Unknown
Registered
2018-12-13
Start date
2018-12-31
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar and Back Myofascitis

Interventions

A:Oral indomethacin and pain relief, intravenous drip of drugs for promoting blood circulation and removing blood stasis, and silver needle heat conduction therapy + Therapy Combined with High Intensi
Group 1:Oral indomethacin and pain relief, intravenous drip of drugs for promoting blood circulation and removing blood stasis, and silver needle heat conduction therapy

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Myofascitis of lumbar and back was diagnosed; (2) Age (> 18 years old) with clear mind; (3) History of fatigue, cold or lumbar sprain in the past; (4) The body mass index (BMI) ranged from 18.5 to 24; (5) agree to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Severe skin lesions or systemic infections were found in the treatment area; (2) Severe hematological diseases or severe abnormalities in coagulation function; (3) suffer from serious heart, liver, kidney, brain and other diseases; (4) Patients with severe psychiatric disorders or who are unable to cooperate; (5) Women during menstruation, pregnancy and lactation; (5) Anaphylaxis with dizzy needles or lidocaine; (6) Cardiac pacemaker installation; (7) Acupuncture and moxibustion or tenderness point injection were performed within 1 month; (8) before admission into the group; (9) Self-rating Depression Scale score (>63).

Design outcomes

Primary

MeasureTime frame
numerical rating scale;Self-Rating Scale of Sleep;Finger ground distance;Activity Limited Score;

Contacts

Public ContactYan Yuan

Affiliated Hospital of Xuzhou Medical University

1046187112@qq.com+86 18052268635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026